Word

DROPSHOT THERAPEUTICS

Status

Pending

Status Code

630

Status Date

Thursday, August 8, 2024

Serial Number

98688672

Mark Type

4

Filing Date

Thursday, August 8, 2024

Trademark Owner History

Dropshot Therapeutics LLC

Classifications

9 Laboratory and scientific apparatus and instruments used for storing nucleic acid molecules, and for amplification, assembly, and modification of genetic fragments, genotyping, gene modification and analysis of cells, samples and biological systems

5 Therapeutic agents; Therapeutic agents for the treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Therapeutic agents, namely, chemicals for pharmaceutical purposes designed to treat different heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; House mark for a full line of pharmaceuticals, therapeutic agents, and therapeutic agent preparations for treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Pharmaceutical and biological preparations based on nucleobase editing, nucleobase modification, nucleic acid editing, gene editing, gene modification, gene modulation, gene reprogramming, gene therapy, genome editing, genome modification, cell therapy, cellular modification, tissue modification, and organ modification for use in human therapeutics; Pharmaceutical preparations for the treatment of genetic diseases and disorders; pharmaceutical preparations in the nature of genetically modified cells for use in the treatment of genetic diseases and disorders; pharmaceutical preparations for detecting genetic predispositions for medical purposes; Pharmaceutical preparations for gene therapy, gene editing, genome editing, and targeted gene replacement and insertion; cell therapies for the treatment of genetic diseases and disorders; gene therapies for the treatment of genetic diseases and disorders

1 Genome editing reagents for research purposes; Biochemicals and biologics, namely, engineered proteins for gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction, all for use in scientific research, pharmaceutical research, diagnostics, and industrial biotechnology; Engineered proteins for use in scientific research and analysis relating to genetic diseases, gene therapy, gene modification and cell therapy; Chemicals, reagents, enzymes, and kits comprising enzymes, nucleotide monomers, solid phase synthesis media, and synthesis plates for laboratory use, all for use in scientific research, namely, for use in synthesizing polynucleotides, namely, for amplifying, assembling and modifying genetic fragments, genotyping, gene modification, and analyzing biological systems, samples and cells, in the course of scientific research conducted in clinical, medical and biological facilities and laboratories

44 Medical services for use in organ perfusion, namely, for gene modification; Medical services for use in organ perfusion via a procedure; Medical and health services relating to DNA, genetics and genetic testing; Medical diagnostic services for testing cancer cells, DNA, RNA, protein samples; Genetic testing and reporting for medical purposes; providing a website featuring medical information regarding genetics; Genetic analysis and reporting services for medical purposes; Medical evaluation services for patients of gene modification, organ transplants, organ perfusion, regenerative medicine, and advanced therapies for purposes of guiding treatment and assessing effectiveness

10 Medical devices and apparatus for delivery of therapeutic agents; Medical devices and apparatus for delivery of therapeutic agents to the heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system; Medical apparatus, namely, blood pumping system for use in organ perfusion; Medical apparatus for use in organ perfusion via a procedure; Organ and tissue perfusion media, namely, fluids to preserve human organs; Medical apparatus for perfusing organs inside or outside human bodies, namely, system for use in artificial organ support; Medical apparatus for use in organ perfusion, namely for gene modification; Testing instruments for medical diagnostic purposes, namely, apparatus for the analysis of body fluids, tissue samples and liquid biopsies in the field of genetics; medical apparatus for gene modification; DNA and RNA testing apparatus for medical use; DNA sample testing apparatus for medical use; diagnostic apparatus for medical use for the detection of genetic particularities, mutations and diseases

42 Scientific research and development for researching and developing therapeutic agents for the treatment of heart, liver, kidney, muscle, aorta, lung, spleen and pulmonary arterial system diseases; Research in the field of gene editing technology; Scientific research and development, namely, gene modification, including gene regulation and gene editing, for researching and developing modified cells and pharmaceuticals; research and development of therapeutics and pharmaceuticals using gene modification and gene editing technologies; medical and scientific research in the fields of genetics, gene modification, genome modification, genome editing, gene editing, genome engineering, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of genetics, gene modification, genome modification, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individual; Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders

Trademark Events

Aug 8, 2024

New Application Entered